Latest filing published 17 Sept 2020 for Fresh Tracks Therapeutics, Inc., €9,287.
Not enough history yet: 0 closed purchases, at least 2 are needed.
This profile gathers the share dealings of Dennison T. Veru across 2 companies, led by Fresh Tracks Therapeutics, Inc. and Refac Optical Group. The record holds 16 filings, for trades running from 6 March 2006 to 16 September 2020.
Purchases make up the whole of the open-market record (2 purchases, €20k). Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Other entries cover 2 share grants and 8 option exercises. So far in 2020, the count stands at 2 purchases and no sales.
The latest filing, published on 17 September 2020, reports a share grant of €9,287 in Fresh Tracks Therapeutics, Inc. The latest purchase dates back some time: it was published 2,228 days ago, on 17 September 2020. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 3 days. For comparison, the SEC allows two business days to file a Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
16 of 16 declarations